Current epidemiological approaches to the metabolic-cognitive syndrome

Journal of Alzheimer's Disease

Volumn 30, Issue SUPPL.2, 2012, Pages

  Panza, Francesco ^a   Solfrizzi, Vincenzo ^b   Logroscino, Giancarlo ^b   Maggi, Stefania ^c   Santamato, Andrea ^d   Seripa, Davide ^a   Pilotto, Alberto ^a,e  

^a CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^b UNIVERSITY OF BARI   (Italy)

^c CNR   (Italy)

^d UNIVERSITY OF FOGGIA   (Italy)

^e S ANTONIO HOSPITAL   (Italy)

Author keywords

Alzheimer's disease; body mass index; dementia; diabetes mellitus; frailty; HDL cholesterol; hypertension; hypertriglyceridemia; insulin resistance; metabolic syndrome; mild cognitive impairment; obesity; predementia syndromes; vascular dementia; vascular risk factors

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; ANTIHYPERTENSIVE AGENT; BETA SECRETASE; BIOLOGICAL MARKER; GAMMA SECRETASE; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; PERINDOPRIL; PLACEBO; TRIACYLGLYCEROL; VITAMIN D;

AGING; ALZHEIMER DISEASE; ANTIHYPERTENSIVE THERAPY; ATHEROSCLEROSIS; BLOOD PRESSURE; BODY MASS; BRAIN INFARCTION; CEREBROVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; COGNITION; COGNITIVE DEFECT; CONTROLLED CLINICAL TRIAL (TOPIC); CORONARY ARTERY DISEASE; DEMENTIA; DIABETES MELLITUS; DISEASE COURSE; FRAIL ELDERLY; HUMAN; HYPERCHOLESTEROLEMIA; HYPERINSULINEMIA; HYPERLIPIDEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; LIFESTYLE MODIFICATION; LONGITUDINAL STUDY; MEMORY; META ANALYSIS (TOPIC); METABOLIC SYNDROME X; MILD COGNITIVE IMPAIRMENT; MINI MENTAL STATE EXAMINATION; MULTIINFARCT DEMENTIA; NEUROFIBRILLARY TANGLE; NEUROPSYCHOLOGICAL TEST; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; PROTEIN PHOSPHORYLATION; RECURRENT DISEASE; REVIEW; RISK FACTOR; RISK REDUCTION; SENILE PLAQUE; STROKE; SYSTEMATIC REVIEW (TOPIC); TREATMENT OUTCOME;

EID: 84862995344     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-2012-111496     Document Type: Review

References (260)

1. Brodaty H, Breteler MM, Dekosky ST, Dorenlot P, Fratiglioni L, Hock C, Kenigsberg PA, Scheltens P, De Strooper B (2011) The world of dementia beyond 2020. J Am Geriatr Soc 59, 923-927.
2. Ferri CP, Prince M, Brayne C, Brodaty H, Fratiglioni L, Ganguli M, Hall K, Hasegawa K, Hendrie H, Huang Y, Jorm A, Mathers C, Menezes PR, Rimmer E, Scazufca M, Alzheimer's Disease, International (2005) Global prevalence of dementia: A Delphi consensus study. Lancet 366, 2112-2117. (Pubitemid 41797645)
3. Prince M, Jackson J, eds (2009) The global prevalence of dementia. In: World Alzheimer report. Alzheimer Disease International, London, pp. 25-45.
4. Neuropathology Group Medical Research Council Cognitive Function, Aging, Study (2001) Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales. Neuropathology Group of the Medical Research Council Cognitive Function and Ageing Study (MRC CFAS). Lancet 357, 169-175.
5. Roman GC (2002) Defining dementia: Clinical criteria for the diagnosisof vascular dementia. Acta Neurol Scand Suppl 178, 6-9.
6. Roman GC, Royall DR (1999) Executive control function: A rational basis for the diagnosis of vascular dementia. Alzheimer Dis Assoc Disord 13 (Suppl 3) , S69-S80.
7. Panza F, D'Introno A, Colacicco AM, Capurso C, Del Parigi A, Caselli RJ, Pilotto A, Argentieri G, Scapicchio PL, Scafato E, Capurso A, Solfrizzi V (2005) Current epidemiology of mild cognitive impairment and other predementia syndromes. Am J Geriatr Psychiatry 13, 633-644. (Pubitemid 41197234)
8. Panza F, Frisardi V, Capurso C, D'Introno A, Colacicco AM, Imbimbo BP, Andrea Santamato A, Vendemmiale G, Seripa D, Pilotto A, Capurso A, Solfrizzi V (2010) Late-life depression, mild cognitive impairment, and dementia: Possible continuum? Am J Geriatr Psychiatry 18, 98-116.
9. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E (1999) Mild cognitive impairment: Clinical characterization and outcome. Arch Neurol 56, 303-308. (Pubitemid 29120227)
10. Winblad B, Palmer K, Kivipelto M, Jelic V, Fratiglioni L, Wahlund LO, Nordberg A, Backman L, Albert M, Almkvist O, Arai H, Basun H, Blennow K, de Leon M, DeCarli C, Erkinjuntti T, Giacobini E, Graff C, Hardy J, Jack C, Jorm A, Ritchie K, van Duijn C, Visser P, Petersen RC (2004) Mild cognitive impairment-beyond controversies, towards a consensus: Report of the International Working Group on Mild Cognitive Impairment. J Intern Med 256, 240-246. (Pubitemid 39222993)
11. Giacobini E, Becker RE (2007) One hundred years after the discovery of Alzheimer's disease. A turning point for therapy? J Alzheimers Dis 12, 37-52. (Pubitemid 47396306)
12. Panza F, Solfrizzi V, Frisardi V, Capurso C, D'Introno A, Colacicco AM, Vendemiale G, Capurso A, Imbimbo BP (2009) Disease-modifying approach to the treatment of Alzheimer's disease: From alpha-secretase activators to gamma-secretase inhibitors and modulators. Drugs Aging 26, 537-555.
13. Frisardi V, Solfrizzi V, Imbimbo BP, Capurso C, D'Introno A, Colacicco AM, Vendemiale G, Seripa D, Pilotto A, Capurso A, Panza (2010) Towards disease-modifying treatment of Alzheimer's disease: Drugs targeting beta-amyloid. Curr Alzheimer Res 7, 40-55.
14. Mangialasche F, Solomon A, Winblad B, Mecocci P, Kivipelto M (2010) Alzheimer's disease: Clinical trials and drug development. Lancet Neurol 9, 702-716.
15. Dubois B, Feldman HH, Jacova C, Dekosky ST, Barberger-Gateau P, Cummings J, Delacourte A, Galasko D, Gauthier S, Jicha G, Meguro K, O'brien J, Pasquier F, Robert P, Rossor M, Salloway S, Stern Y, Visser PJ, Scheltens P (2007) Research criteria for the diagnosis of Alzheimer's disease: Revising the NINCDS-ADRDA criteria. Lancet Neurol 6, 734-746. (Pubitemid 47058377)
16. Dubois B, Feldman HH, Jacova C, Cummings JL, Dekosky ST, Barberger-Gateau P, Delacourte A, Frisoni G, Fox NC, Galasko D, Gauthier S, Hampel H, Jicha GA, Meguro K, O'Brien J, Pasquier F, Robert P, Rossor M, Salloway S, Sarazin M, de Souza LC, Stern Y, Visser PJ, Scheltens P (2010) Revising the definition of Alzheimer's disease: A new lexicon. Lancet Neurol 9, 1118-1127.
17. McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR Jr, Kawas CH, Klunk WE, Koroshetz WJ, Manly JJ, Mayeux R, Mohs RC, Morris JC, Rossor MN, Schel-tens P, Carrillo MC, Thies B, Weintraub S, Phelps CH (2011) The diagnosis of dementia due to Alzheimer's dis ease: Recommendations from the National Institute on Aging-Alzheimer's association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 7, 263-269.
18. Albert MS, Dekosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, Gamst A, Holtzman DM, Jagust WJ, Petersen RC, Snyder PJ, Carrillo MC, Thies B, Phelps CH (2011) The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 7, 270-279.
19. Sperling RA, Aisen PS, Beckett LA, Bennett DA, Craft S, Fagan AM, Iwatsubo T, Jack CR Jr, Kaye J, Montine TJ, Park DC, Reiman EM, Rowe CC, Siemers E, Stern Y, Yaffe K, Carrillo MC, Thies B, Morrison-Bogorad M, Wagster MV, Phelps CH (2011) Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 7, 280-292.
20. Kivipelto M, Ngandu T, Laatikainen T, Winblad B, Soini-nen H, Tuomilehto J (2006) Risk Score for prediction of dementia risk in 20 years among middle aged people: A longitudinal population based study. Lancet Neurol 9, 735-741. (Pubitemid 44205512)
21. Kivipelto M, Solomon A (2008) Alzheimer's disease - the ways of prevention. J Nutr Health Aging 12, 89S-94S. (Pubitemid 351156023)
22. Solfrizzi V, Capurso C, D'Introno A, Colacicco AM, Santamato A, Ranieri M, Fiore P, Capurso A, Panza F (2008) Lifestyle-related factors in predementia and dementia syndromes. Expert Rev Neurother 8, 133-158.
23. Peters R (2009) The prevention of dementia. Int J Geriatr Psychiatry 24, 452-458.
24. de la Torre JC (2010) Basics of Alzheimer's disease prevention. J Alzheimers Dis 20, 687-688.
25. de la Torre JC (2010) Vascular risk factor detection and control may prevent Alzheimer's disease. Ageing Res Rev 9, 218-225.
26. Panza F, D'Introno A, Colacicco AM, Capurso C, Parigi AD, Capurso SA, Caselli RJ, Pilotto A, Scafato E, Capurso A, Solfrizzi V (2006) Cognitive frailty: Predementia syndrome and vascular risk factors. Neurobiol Aging 27, 933-940. (Pubitemid 43732521)
27. Grodstein F (2007) Cardiovascular risk factors and cognitive function. Alzheimer Dement 3, S16-S22. (Pubitemid 46554900)
28. Purnell C, Gao S, Callahan CM, Hendrie HC (2009) Cardiovascular risk factors and incident Alzheimer disease: A systematic review of the literature. Alzheimer Dis Assoc Disord 23, 1-10.
29. Milionis HJ, Florentin M, Giannopoulos S (2008) Metabolic syndrome and Alzheimer's disease: A link to a vascular hypothesis? CNS Spectr 13, 606-613.
30. Panza F, Frisardi V, Capurso C, Imbimbo BP, Vendemiale G, Santamato A, D'Onofrio G, Seripa D, Sancarlo D, Pilotto A, Solfrizzi V (2010) Metabolic syndrome and cognitive impairment: Current epidemiology and possible underlying mechanisms. J Alzheimers Dis 21, 691-724.
31. Barzilay JI, Stein PK (2011) Association of the metabolic syndrome with age-related, nonatherosclerotic, chronic medical conditions. Metab Syndr Relat Disord 9, 327-335.
32. Panza F, Frisardi V, Seripa D, Imbimbo BP, Sancarlo D, D'Onofrio G, Addante F, Paris F, Pilotto A, Solfrizzi V (2011) Metabolic syndrome, mild cognitive impairment, and dementia. Curr Alzheimer Res 8, 492-509.
33. Haffner SM (2006) The metabolic syndrome: Inflammation, diabetes mellitus, and cardiovascular disease. Am J Cardiol 97, 3A-11A. (Pubitemid 43139714)
34. Gami AS, Witt BJ, Howard DE, Erwin PJ, Gami LA, Somers VK, Montori VM (2007) Metabolic syndrome and risk of incident cardiovascular events and death: A systematic review and meta-analysis of longitudinal studies. J Am Coll Cardiol 49, 403-414. (Pubitemid 46135879)
35. Kwon HM, Kim BJ, Lee SH, Choi SH, Oh BH, Yoon BW (2006) Metabolic syndrome as an independent risk factor of silent brain infarction in healthy people. Stroke 37, 466-472.
36. Wang J, Ruotsalainen S, Moilanen L, Lepistö P, Laakso M, Kuusisto J (2008) The metabolic syndrome predicts incident stroke: A 14-year follow-up study in elderly people in Finland. Stroke 39, 1078-1083. (Pubitemid 351444669)
37. Luchsinger JA, Gustafson DR (2009) Adiposity, type 2 diabetes, and Alzheimer's disease. J Alzheimers Dis 16, 693-704.
38. Frisardi V, Solfrizzi V, Capurso C, Imbimbo BP, Vendemiale G, Seripa D, Pilotto A, Panza F (2010) Is insulin resistant brain state a central feature of the metabolic-cognitive syndrome? J Alzheimers Dis 21, 57-63.
39. Frisardi V, Solfrizzi V, Seripa D, Capurso C, Santamato A, Sancarlo D, Vendemiale G, Pilotto A, Panza F (2010) Metabolic-cognitive syndrome: A cross-talk between metabolic syndrome and Alzheimer's disease. Ageing Res Rev 9, 399-417.
40. Ford ES, Giles WH, Dietz WH (2002) Prevalence of the metabolic syndrome among US adults: Findings from the third National Health and Nutrition Examination Survey. JAMA 287, 356-359. (Pubitemid 34251969)
41. Avogaro P, Crepaldi G, Enzi G, Tiengo A (1967) Association of hyperlipemia, diabetes mellitus and mild obesity. Acta Diabetol Lat 4, 572-590.
42. Alberti KG, Zimmet PZ (1998) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15, 539-553. (Pubitemid 28319935)
43. Reaven GM (1988) Banting lecture 1988 Role of insulin resistance in human disease. Diabetes 37, 1595-1607. (Pubitemid 19004941)
44. Meigs JB (2000) Invited commentary: Insulin resistance syndrome? Syndrome X? Multiple metabolic syndrome? A syndrome at all? Factor analysis reveals patterns in the fabric of correlated metabolic risk factors. Am J Epidemiol 152, 908-911.
45. Sakkinen PA, Wahl P, Cushman M, Lewis MR, Tracy RP (2000) Clustering of procoagulation, inflammation, and fibrinolysis variables with metabolic factors in insulin resistance syndrome. Am J Epidemiol 152, 897-907.
46. Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C (2004) National Heart, Lung, and Blood Institute; American Heart Association, Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Arterioscler Thromb Vasc Biol 24, 13-18.
47. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) (2001) Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP). JAMA 285, 2486-2497.
48. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC Jr, Spertus JA, Costa F, American Heart Association; National Heart, Lung, and Blood Institute (2005) Diagnosis and management of the metabolic syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112 2735-2752. (Pubitemid 41532612)
49. Alberti KG, Zimmet P, Shaw J, IDF Epidemiology Task Force Consensus Group (2005) The metabolic syndrome-a new worldwide definition. Lancet 366, 1059-1062. (Pubitemid 41338752)
50. Balkau B, Charles MA (1999) Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR). Diabet Med 16, 442-443.
51. Einhorn D, Reaven GM, Cobin RH, Ford E, Ganda OP, Handelsman Y, Hellman R, Jellinger PS, Kendall D, Krauss RM, Neufeld ND, Petak SM, Rodbard HW, Seibel JA, Smith DA, Wilson PW (2003) American College of Endocrinology position statement on the insulin resistance syndrome. Endocr Pract 9, 237-252.
52. Grundy SM (2007) Metabolic syndrome: A multiplex cardiovascular risk factor. J Clin Endocrinol Metab 92, 399-404.
53. Maggi S, Noale M, Zambon A, Limongi F, Romanato G, Crepaldi G, ILSA Working Group (2008) Validity of the ATP III diagnostic criteria for the metabolic syndrome in an elderly Italian Caucasian population: The Italian Longitudinal Study on Aging. Atherosclerosis 197, 877-882. (Pubitemid 351417887)
54. Gorelick PB (2004) Risk factors for vascular dementia and Alzheimer disease. Stroke 35 (11 Suppl 1) , 2620-2622. (Pubitemid 39458352)
55. Luchsinger JA, Reitz C, Honig LS, Tang MX, Shea S, Mayeux R (2005) Aggregation of vascular risk factors and risk of incident Alzheimer disease. Neurology 65, 545-551. (Pubitemid 41170713)
56. Kivipelto M, Helkala EL, Hänninen T, Laakso MP, Hallikainen M, Alhainen K, Soininen H, Tuomilehto J, Nissinen A (2001) Midlife vascular risk factors and Alzheimer's disease in later life: Longitudinal; population based study. BMJ 322, 1447-1451. (Pubitemid 32575406)
57. Lopez OL, Jagust WJ, Dulberg C, Becker JT, DeKosky ST, Fitzpatrick A, Breitner J, Lyketsos C, Jones B, Kawas C, Carlson M, Kuller LH (2003) Risk factors for mild cognitive impairment in the cardiovascular health study cognition study. Part 2. Arch Neurol 60, 1394-1139.
58. DeCarli C, Mungas D, Harvey D, Reed B, Weiner M, Chui H, Jagust W (2004) Memory impairment; but not cerebrovas-cular disease; predicts progression of MCI to dementia. Neurology 63, 220-227. (Pubitemid 38971118)
59. Solfrizzi V, Panza F, Colacicco AM, D'Introno A, Capurso C, Torres F, Grigoletto F, Maggi S, Del Parigi A, Reiman EM, Caselli RJ, Scafato E, Farchi G, Capurso A, Italian Longitudinal Study on Aging Working Group (2004) Vascular risk factors; incidence of MCI; and rates of progression to dementia. Neurology 63, 1882-1891. (Pubitemid 39532385)
60. Ravaglia G, Forti P, Maioli F, Martelli M, Servadei L, Brunetti N, Pantieri G, Mariani E (2006) Conversionof mild cognitive impairment to dementia: Predictive role of mild cognitive impairment subtypes and vascular risk factors. Dement Geriatr Cogn Disord 21, 51-58. (Pubitemid 41797971)
61. Mariani E, Monastero R, Ercolani S, Mangialasche F, Caputo M, Feliziani FT, Vitale DF, Senin U, Mecocci P, ReGAl Study Group (2007) Vascular risk factors in mild cognitive impairment subtypes. Findings from the ReGAl project. Dement Geriatr Cogn Disord 24, 448-456. (Pubitemid 350175905)
62. Paradise MB, Glozier NS, Naismith SL, Davenport TA, Hickie IB (2011) Subjective memory complaints, vascular risk factors and psychological distress in the middle-aged: A cross-sectional study. BMC Psychiatr 11, 108.
63. Li J, Wang YJ, Zhang M, Xu ZQ, Gao CY, Fang CQ, Yan JC, Zhou HD, Chongqing Ageing Study Group (2011) Vascular risk factors promote conversion from mild cognitive impairmenttoAlzheimer disease. Neurology76, 1485-1491.
64. Prasad K, Wiryasaputra L, Ng A, Kandiah N (2011) White matter disease independently predicts progression from mild cognitive impairment to Alzheimer's disease in a clinic cohort. Dement Geriatr Cogn Disord 31, 431-434.
65. Villeneuve S, Massoud F, Bocti C, Gauthier S, Belleville S (2011) The nature of episodic memory deficits in MCI with and without vascular burden. Neuropsychologia 49, 3027-3035.
66. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J (2005) Global burden of hypertension: Analysis of worldwide data. Lancet 365, 217-223. (Pubitemid 40138015)
67. Peters R, Beckett N (2009) Hypertension, dementia, and antihypertensive treatment: Implications for the very elderly. Curr Hypertens Rep 11, 277-282.
68. Elias MF, Wolf PA, D'Agostino RB, Cobb J, White LR (1993) Untreated blood pressure level is inversely related to cognitive functioning: The Framingham study. Am J Epidemiol 138, 353-364. (Pubitemid 23289288)
69. Launer LJ, Masaki K, Petrovitch H, Foley D, Havlik RJ (1995) The association between midlife blood pressure levels and late-life cognitive function. JAMA 274, 1846-1851. (Pubitemid 26001260)
70. Kilander L, Nyman H, Boberg M, Hansson L, Lithell H (1998) Hypertension is related to cognitive impairment. A 20-year follow-up of 999 men. Hypertension 31, 780-786. (Pubitemid 28108576)
71. Tzourio C, Dufouil C, Ducimetière P, Alpérovitch A (1999) Cognitive decline in individuals with high blood pressure: A longitudinal study in the elderly. EVA Study Group. Epidemiology of Vascular Aging. Neurology 53, 1948-1952.
72. DeCarli C, Miller BL, Swan GE, Reed T, Wolf PA, Carmelli D (2001) Cerebrovascular and brain morphologic correlates of mild cognitive impairment in the National Heart, Lung, and Blood Institute Twin Study. Arch Neurol 58, 643-647. (Pubitemid 32295717)
73. Tervo S, Kivipelto M, Hänninen T, Vanhanen M, Hallikainen M, Mannermaa A, Soininen H (2004) Incidence and risk factors for mild cognitive impairment: A population-based three-year follow-up study of cognitively healthy elderly subjects. Dement Geriatr Cogn Disord 17, 196-203. (Pubitemid 38339747)
74. Reitz C, Tang MX, Manly J, Mayeux R, Luchsinger JA (2007) Hypertension and the risk of mild cognitive impair ment. Arch Neurol 64, 1734-1740. (Pubitemid 350254935)
75. Panza F, Capurso C, D'Introno A, Colacicco AM, Santamato A, Capurso A, Solfrizzi V (2008) Hypertension and mild cognitive impairment subtypes. Arch Neurol 65, 992-993. (Pubitemid 352008495)
76. Kloppenborg RP, van den Berg E, Kappelle LJ, Biessels GJ (2008) Diabetes and other vascular risk factors for demen tia: Which factor matters most? A systematic review. Eur J Pharmacol 585, 97-108.
77. Kerola T, Kettunen R, Nieminen T (2011) The complex interplay of cardiovascular system and cognition: How to predict dementia in the elderly? Int J Cardiol 150, 123-129.
78. Birns J, Kalra L (2009) Cognitive function and hypertension. J Hum Hypertens 23, 86-96.
79. Gorelick PB, Scuteri A, Black SE, Decarli C, Greenberg SM, Iadecola C, Launer LJ, Laurent S, Lopez OL, Nyen-huis D, Petersen RC, Schneider JA, Tzourio C, Arnett DK, Bennett DA, Chui HC, Higashida RT, Lindquist R, Nils-son PM, Roman GC, Sellke FW, Seshadri S, on behalf of the American Heart Association Stroke Council, Council on Epidemiology and Prevention, Council on Cardiovascular Nursing, Council on Cardiovascular Radiology and Intervention, and Council on Cardiovascular Surgery and Anesthesia (2011) Vascular Contributions to Cognitive Impairment and Dementia: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke 42, 2672-2713.
80. Elias MF, Beiser A, Wolf PA, Au R, White RF, D'Agostino RB (2000) The preclinical phase of alzheimer disease: A 22-year prospective study of the Framingham Cohort. Arch Neurol 57, 808-813. (Pubitemid 30397182)
81. Debette S, Seshadri S (2009) Vascular risk factors and dementia revisited. J Neurol Neurosurg Psychiatry80, 1183-1184.
82. Alonso A, Mosley TH Jr, Gottesman RF, Catellier D, Shar-rett AR, Coresh J (2009) Risk of dementia hospitalization associated with cardiovascular risk factors in midlife and older age: TheAtherosclerosis RiskinCommunities (ARIC) study. J Neurol Neurosurg Psychiatry 80, 1194-1201.
83. Whitmer RA, Sidney S, Selby J, Johnston SC, Yaffe K (2005) Midlife cardiovascularrisk factors andriskofdemen-tia in late life. Neurology 64, 277-281.
84. Launer LJ, Ross GW, Petrovitch H, Masaki K, Foley D, White LR, Havlik RJ (2000) Midlife blood pressure and dementia: The Honolulu-Asia aging study. Neurobiol Aging 21, 49-55. (Pubitemid 30224785)
85. Kivipelto M, Helkala E-L, Laakso MP, Hänninen T, Hallikainen M, Alhainen K, Iivonen S, Mannermaa A, Tuomilehto J, Nissinen A, Soininen H (2002) Apolipopro-tein E ε4 allele, elevated midlife total cholesterol level and high midlife systolic blood pressure are independent risk factors for late-life Alzheimer's disease. Ann Intern Med 137, 149-155. (Pubitemid 34827510)
86. Skoog I, Lernfelt B, Landahl S, Palmertz B, Andreasson LA, Nilsson L, Persson G, Odén A, Svanborg A (1996) A 15-year longitudinal study of blood pressure and dementia. Lancet 347, 1141-1145. (Pubitemid 126512042)
87. Guo Z, Viitanen M, Fratiglioni L, Winblad B (1996) Low blood pressure and dementia in elderly people: The Kung-sholmen project. BMJ 312, 805-808. (Pubitemid 26099298)
88. Farmer ME, Kittner SJ, Abbott RD, Wolz MM, Wolf PA, White LR (1990) Longitudinally measured blood pressure, antihypertensive medication use, and cognitive performance: The Framingham Study. J Clin Epidemiol 43, 475-480. (Pubitemid 20153148)
89. Qiu C, von Strauss E, Fastbom J, Winblad B, Fratiglioni L (2003) Low blood pressure and risk of dementia in the Kungsholmen project. Arch Neurol 60, 223-228. (Pubitemid 36193966)
90. Stewart R, Xue QL, Masaki K, Petrovitch H, Ross GW, White LR, Launer LJ (2009) Change in blood pressure and incident dementia: A 32-year prospective study. Hypertension 54, 233-240.
91. Qiu C, Winblad B, Fratiglioni L (2005) The age-dependent relation of blood pressure to cognitive function and dementia. Lancet Neurol 4, 487-499. (Pubitemid 40982459)
92. SHEP Cooperative Research Group (1991) Prevention of stroke by antihypertensive drug treatment in older persons with isolated hypertension. JAMA 265, 3255-3264.
93. Cervilla JA, Prince M, Joels S, Lovestone S, Mann A (2000) Long-term predictors of cognitive outcome in a cohort of older people with hypertension. Br J Psychiatry 177, 66-71. (Pubitemid 30450667)
94. Lithell H, Hansson L, Skoog I, Elmfeldt D, Hofman A, Olofsson B, Trenkwalder P, Zanchetti A, SCOPE Study Group (2003) The Study on Cognition and Prognosis in the Elderly (SCOPE) : Principal results of a randomized doubleblind intervention trial. J Hypertens 21, 875-886. (Pubitemid 36677151)
95. Pérez-Stable EJ, Halliday R, Gardiner PS, Baron RB, Hauck WW, Acree M, Coates TJ (2000) The effects of propranolol on cognitive function and quality of life: A randomized trial among patients with diastolic hypertension. Am J Med 108, 359-365. (Pubitemid 30162953)
96. The PROGRESS Collaborative Group (2003) Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease. Arch Intern Med 163, 1069-1075.
97. Forette F, Seux ML, Staessen JA, Thijs L, Birkenhäger WH, Babarskiene MR, Babeanu S, Bossini A, Gil-Extremera B, Girerd X, Laks T, Lilov E, Moisseyev V, Tuomilehto J, Vanhanen H, Webster J, Yodfat Y, Fagard R (1998) Prevention of dementia in a randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial. Lancet 352, 1347-1351. (Pubitemid 28510916)
98. Forette F, Staessen J, Lutgarde T, Birkenhager W (1999) Prevention of dementia. Lancet 353, 236-237.
99. Peters R, Beckett N, Nunes M, Fletcher A, Forette F, Bulpitt C (2006) A substudy protocol of the Hypertension in the Very Elderly Trial assessing cognitive decline and dementia incidence (HYVET-COG) : An ongoing randomized, double-blind, placebo-controlled trial. Drugs Aging 23, 83-92. (Pubitemid 43290887)
100. Beckett NS, Peters R, Fletcher AE, Staessen JA, Liu L, Dumitrascu D, Stoyanovsky V, Antikainen RL, Nikitin Y, Anderson C, Belhani A, Forette F, Rajkumar C, Thijs L, Banya W, Bulpitt CJ, HYVET Study Group (2008) Treatment of hypertension in patients 80 years of age or older. N Engl J Med 358, 1887-1898. (Pubitemid 351620109)
101. Peters R, Beckett N, Forette F, Tuomilehto J, Clarke R, Ritchie C, Waldman A, Walton I, Poulter R, Ma S, Comsa M, Burch L, Fletcher A, Bulpitt C, HYVET investigators (2008) Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG). A double-blind, placebo-controlled trial. Lancet Neurol 7 683-689.
102. Birns J, Morris R, Donaldson N, Kalra L (2006) The effects of blood pressure reduction on cognitive function: A review of effects based on pooled data from clinical trials. J Hypertens 24, 1907-1914. (Pubitemid 44371252)
103. Staessen JA, Thijs L, Richart T, Odili AN, Birkenhäger WH (2011) Placebo-controlled trials of blood pressure-lowering therapies for primary prevention of dementia. Hypertension 57, e6-e7.
104. McGuinness B, Todd S, Passmore P, Bullock R (2006) The effects of blood pressure lowering on development of cognitive impairment and dementia in patients without apparent prior cerebrovascular disease. Cochrane Database Syst Rev, CD004034.
105. McGuinness B, Todd S, Passmore P, Bullock R (2009) Blood pressure lowering in patients without prior cerebrovascular disease for prevention of cognitive impairment and dementia. Cochrane Database Syst Rev, CD004034.
106. Craft S (2009) The role of metabolic disorders in Alzheimer disease and vascular dementia: Two roads converged. Arch Neurol 66, 300-305.
107. Arvanitakis Z, Wilson RS, Bienias JL, Evans DA, Bennett DA (2004) Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function. Arch Neurol 61, 661-666. (Pubitemid 38637681)
108. Duron E, Hanon O (2008) Vascular risk factors, cognitive decline, and dementia. Vasc Health Risk Manag 4, 363-381. (Pubitemid 351711965)
109. Yaffe K, Blackwell T, Kanaya AM, Davidowitz N, Barrett-Connor E, Krueger K (2004) Diabetes, impaired fasting glucose, and development of cognitive impairment in older women. Neurology 63, 658-663. (Pubitemid 39100821)
110. Roriz-Filho JS, Sá-Roriz TM, Rosset I, Camozzato AL, Santos AC, Chaves ML, Moriguti JC, Roriz-Cruz M (2009) (Pre) diabetes, brain aging, and cognition. Biochim Biophys Acta 1792, 432-443.
111. Miles W, Root H (1922) Psychologic tests appliestodiabetic patients. Arch Int Med 30, 767-777.
112. Brands AM, Biessels GJ, de Haan EH, Kappelle LJ, Kessels RP (2005) The effects of type 1 diabetes on cognitive performance: A meta-analysis. Diabetes Care 28, 726-735. (Pubitemid 40315341)
113. Yaffe K (2007) Metabolic syndrome and cognitive disorders: Is the sum greater than its parts? Alzheimer Dis Assoc Disord 21, 167-171. (Pubitemid 46878980)
114. Kanaya AM, Barrett-Connor E, Gildengorin G, Yaffe K (2004) Change in cognitive function by glucose tolerance status in older adults: A 4-year prospective study of the Rancho Bernardo study cohort. Arch Intern Med 164, 1327-1333. (Pubitemid 38828884)
115. Grodstein F, Chen J, Wilson RS, Manson JE Nurses' Health Study (2001) Type 2 diabetes and cognitive function in community-dwelling elderly women. Diabetes Care 24, 1060-1065. (Pubitemid 33716377)
116. Gregg EW, Yaffe K, Cauley JA, Rolka DB, Blackwell TL, Narayan KM, Cummings SR (2000) Is diabetes associated with cognitive impairment and cognitive decline among older women? Study of Osteoporotic Fractures Research Group. Arch Intern Med 160, 174-180. (Pubitemid 30054336)
117. Allen KV, Frier BM, Strachan MW (2004) The relationship between type 2 diabetes and cognitive dysfunction: Longitudinal studies and their methodological limitations. Eur J Pharmacol 490, 169-175. (Pubitemid 38482170)
118. Elias MF, Elias PK, Sullivan LM, Wolf PA, D'Agostino RB (2005) Obesity, diabetes and cognitive deficit: The Fram-ingham Heart Study. Neurobiol Aging 26 (Suppl 1) , 11-16.
119. Saczynski JS, Jonsdottir MK, Garcia ME, Jonsson PV, Peila R, Eiriksdottir G, Olafsdottir E, Harris TB, Gudnason V, Launer LJ (2008) Cognitive impairment: An increasingly important complication of type 2 diabetes: The Age, Gene/Environment Susceptibility-Reykjavik study. Am J Epidemiol 168, 1132-1139.
120. Cukierman-Yaffe T, Gerstein HC, Williamson JD, Lazar RM, Lovato L, Miller ME, Coker LH, Murray A, Sullivan MD, Marcovina SM, Launer LJ (2009) Relationship between baseline glycemic control and cognitive function in individuals with type 2 diabetes and other cardiovascular risk factors: The Action to Control Cardiovascular Risk in Diabetes-Memory in Diabetes (ACCORD-MIND) trial. Diabetes Care 32, 221-226.
121. Yaffe K, Blackwell T, Whitmer RA, Krueger K, Barrett Connor E (2006) Glycosylated hemoglobin level and development of mild cognitive impairment or dementia in older women. J Nutr Health Aging 10, 293-295.
122. Vanhanen M, Koivisto K, Kuusisto J, Mykkanen L, Helkala EL, Hanninen T, Riekkinen P Sr, Soininen H, Laakso M (1998) Cognitive function in an elderly population with persistent impaired glucose tolerance. Diabetes Care 21, 398-402. (Pubitemid 28101075)
123. Fontbonne A, Berr C, Ducimetiere P, Alperovitch A (2001) Changes in cognitive abilities over a 4-year period are unfavorably affected in elderly diabetic subjects: Results of the Epidemiology of Vascular Aging Study. Diabetes Care 24, 366-370. (Pubitemid 32119140)
124. Lindeman RD, Romero LJ, LaRue A, Yau CL, Schade DS, Koehler KM, Baumgartner RN, Garry PJ (2001) A biethnic community survey of cognition in participants with type 2 diabetes, impaired glucose tolerance, and normal glucose tolerance: The New Mexico Elder Health Survey. Diabetes Care 24, 1567-1572. (Pubitemid 33716450)
125. Kumari M, Marmot M (2005) Diabetes and cognitive function in a middle-aged cohort: Findings from the Whitehall II study. Neurology 65, 1597-1603. (Pubitemid 41689475)
126. Scott RD, Kritz-Silverstein D, Barrett-Connor E, Wiederholt WC (1998) The association of non-insulin-dependent diabetes mellitus and cognitive function in an older cohort. J Am Geriatr Soc 46, 1217-1222. (Pubitemid 28467423)
127. Cukierman T, Gerstein HC, Williamson JD (2005) Cognitive decline and dementia in diabetes-systematic overview of prospective observational studies. Diabetologia 48, 2460-2469. (Pubitemid 41738208)
128. van den Berg E, de Craen AJ, Biessels GJ, Gussekloo J, Westendorp RG (2006) The impact of diabetes mellitus on cognitive decline in the oldest of the old: A prospective population-based study. Diabetologia 49, 2015-2023.
129. Biessels GJ, Staekenborg S, Brunner E, Brayne C, Scheltens P (2006) Riskof dementia in diabetes mellitus: A systematic review. Lancet Neurol 5, 64-74. (Pubitemid 41790697)
130. Luchsinger JA (2010) Diabetes, related conditions, and dementia. J Neurol Sci 299, 35-38.
131. Luchsinger JA, Tang MX, Stern Y, Shea S, Mayeux R (2001) Diabetes mellitus and risk of Alzheimer's disease and dementia with stroke in a multiethnic cohort. Am J Epidemiol 154, 635-641. (Pubitemid 32888781)
132. MacKnight C, Rockwood K, Awalt E, McDowell I (2002) Diabetes mellitus and the risk of dementia, Alzheimer's disease and vascular cognitive impairment in the Canadian Study of Health and Aging. Dement Geriatr Cogn Disord 14, 77-83. (Pubitemid 36152948)
133. Luchsinger JA, Reitz C, Patel B, Tang M-X, Manly JJ, Mayeux R (2007) Relation of diabetes to mild cognitive impairment. Arch Neurol 64, 570-575. (Pubitemid 46588347)
134. Roberts RO, Geda YE, Knopman DS, Christianson TJ, Pankratz VS, Boeve BF, Vella A, Rocca WA, Petersen RC (2008) Association of duration and severity of diabetes mellitus with mild cognitive impairment. Arch Neurol 65, 1066-1073.
135. Luchsinger JA, Tang MX, Shea S, Mayeux R (2004) Hyper-insulinemia and risk of Alzheimer disease. Neurology 63, 1187-1192.
136. Watson GS, Craft S (2003) The role of insulin resistance in the pathogenesis of Alzheimer's disease: Implications for treatment. CNS Drugs 17, 27-45. (Pubitemid 36044347)
137. Kuusisto J, Koivisto K, Mykkanen L, Helkala EL, Vanhanen M, Hanninen T, Kervinen K, Kesaniemi YA, Riekkinen PJ, Laakso M (1997) Associationbetween featuresofthe insulin resistance syndrome and Alzheimer's disease independently of apolipoprotein E4 phenotype: Cross-sectional population based study. BMJ 315, 1045-1049. (Pubitemid 27458392)
138. Curb JD, Rodriguez BL, Abbott RD, Petrovitch H, Ross GW, Masaki KH, Foley D, Blanchette PL, Harris T, Chen R, White LR (1999) Longitudinal association of vascular and Alzheimer's dementias, diabetes, and glucose tolerance. Neurology 52, 971-975. (Pubitemid 29161605)
139. Yoshitake T, Kiyohara Y, Kato I, Ohmura T, Iwamoto H, Nakayama K, Ohmori S, Nomiyama K, Kawano H, Ueda K, Sueishi K, Tsuneyoshi M, Fujishima M (1995) Incidence and risk factors of vascular dementia and Alzheimer's dis-easeinadefined elderly Japanese population: The Hisayama Study. Neurology 45, 1161-1168.
140. Ott A, Stolk RP, van Harskamp F, Pols HA, Hofman A, Breteler MM (1999) Diabetes mellitus and the risk of dementia: The Rotterdam Study. Neurology 53, 1937-1942.
141. Brayne C, Gill C, Huppert FA, Barkley C, Gehlhaar E, Girling DM, O'Connor DW, Paykel ES (1998) Vascularrisks and incident dementia: Results from a cohort study of the very old. Dement Geriatr Cogn Disord 9, 175-180. (Pubitemid 28171890)
142. Leibson CL, Rocca WA, Hanson VA, Cha R, Kokmen E, O'Brien PC, Palumbo PJ (1997) Risk of dementia among persons with diabetes mellitus: A population- based cohort study. Am J Epidemiol 145, 301-308. (Pubitemid 27082028)
143. Peila R, Rodriguez BL, Launer LJ, Honolulu-Asia Aging S (2002) Type 2 diabetes, APOE gene, and the risk for demen tiaand related pathologies: The Honolulu-AsiaAging Study. Diabetes 51, 1256-1262. (Pubitemid 34438377)
144. Xu WL, Qiu CX, Wahlin A, Winblad B, Fratiglioni L (2004) Diabetes mellitus and risk of dementia in the Kung-sholmen project: A 6-year follow-up study. Neurology 63, 1181-1186. (Pubitemid 39350014)
145. Xu W, Qiu C, Winblad B, Fratiglioni L (2007) The effect of borderline diabetes on the risk of dementia and Alzheimer's disease. Diabetes 56, 211-216.
146. Luchsinger JA, Reitz C, Honig LS, Tang MX, Shea S, Mayeux R (2005) Aggregation of vascular risk factors and risk of incident Alzheimer disease. Neurology 65, 545-551. (Pubitemid 41170713)
147. Schnaider Beeri M, Goldbourt U, Silverman JM, Noy S, Schmeidler J, Ravona-Springer R, Sverdlick A, Davidson M (2004) Diabetes mellitus in midlife and the risk of dementia three decades later. Neurology 63, 1902-1907. (Pubitemid 39532388)
148. Anthopoulos PG, Hamodrakas SJ, Bagos PG (2010) Apolipoprotein E polymorphisms and type 2 diabetes: A meta-analysis of 30 studies including 5423 cases and 8197 controls. Mol Genet Metab 100, 283-291.
149. Seripa D, Panza F, Franceschi M, D'Onofrio G, Solfrizzi V, Dallapiccola B, Pilotto A (2009) Non-apolipoprotein E and apolipoprotein E genetics of sporadic Alzheimer's disease. Ageing Res Rev 8, 214-236.
150. Gustafson DR, Karlsson C, Skoog I, Rosengren L, Lissner L, Blennow K (2007) Mid-life adiposity factors relate to blood-brain barrier integrity in late life. J Intern Med 262, 643-650. (Pubitemid 350135196)
151. Elias MF, Elias PK, Sullivan LM, Wolf PA, D'Agostino RB (2003) Lower cognitive function in the presence of obesity and hypertension: The Framingham heart study. Int J Obes Relat Metab Disord 27, 260-268. (Pubitemid 36255810)
152. Rennie KL, Jebb SA (2005) Prevalence of obesity in Great Britain. Obes Rev 6, 11-12.
153. Waldstein SR, Katzel LI (2006) Interactive relations of central versus total obesity and blood pressure to cognitive function. Int J Obes (Lond) 30, 201-207. (Pubitemid 41790798)
154. Sabia S, Kivimaki M, Shipley MJ, Marmot MG, Singh-Manoux A (2009) Body mass index over the adult life course and cognitionin late midlife: The Whitehall II Cohort Study. Am J Clin Nutr 89, 601-607.
155. Nourhashémi F, Deschamps V, Larrieu S, Letenneur L, Dartigues JF, Barberger-Gateau P, PAQUID study. Personnes Agées Quid (2003) Body mass index and incidence of dementia: The PAQUID study. Neurology 60, 117-119. (Pubitemid 36070657)
156. Stewart R, Masaki K, Xue QL, Peila R, Petrovitch H, White LR, Launer LJ (2005) A32-year prospective studyofchange in body weight and incident dementia: The Honolulu-Asia Aging Study. Arch Neurol 62, 55-60. (Pubitemid 40105036)
157. White H, Pieper C, Schmader K, Fillenbaum G (1996) Weight change in Alzheimer's disease. J Am Geriatr Soc 44, 265-272. (Pubitemid 26081092)
158. Wang SY (2002) Weight loss and metabolic changes in dementia. J Nutr Health Aging 6, 201-205. (Pubitemid 34625302)
159. Gustafson D (2006) Adiposity indices and dementia. Lancet Neurol 5, 713-720. (Pubitemid 44062421)
160. Gorospe EC, Dave JK (2007) The risk of dementia with increased body mass index. Age Ageing 36, 23-29. (Pubitemid 47078643)
161. Kivipelto M, Ngandu T, Fratiglioni L, Viitanen M, Kareholt I, Winblad B, Helkala EL, Tuomilehto J, Soininen H, Nissinen A (2005) Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease. Arch Neurol 62, 1556-1560. (Pubitemid 41434560)
162. Whitmer RA, Gunderson EP, Barrett-Connor E, Quesen-berryCP Jr, Yaffe K (2005) Obesity in middle age and future risk of dementia: A 27 year longitudinal population based study. BMJ 330, 1360.
163. Whitmer RA, Gustafson DR, Barrett-Connor E, Haan MN, Gunderson EP, Yaffe K (2008) Central obesity and increased risk of dementia more than three decades later. Neurology 71, 1057-1064.
164. Gustafson D, Rothenberg E, Blennow K, Steen B, Skoog I (2003) An 18-year follow-up of overweight and risk of Alzheimer disease. Arch Intern Med 163, 1524-1528. (Pubitemid 36835095)
165. Beydoun MA, Lhotsky A, Wang Y, Dal Forno G, An Y, Metter EJ, Ferrucci L, O'Brien R, Zonderman AB (2008) Association of adiposity status and changes in early to mid adulthood with incidence of Alzheimer's disease. Am J Epidemiol 168, 1179-1189.
166. Power BD, Alfonso H, Flicker L, Hankey GJ, Yeap BB, Almeida OP (2011) Body adiposity in later life and the incidence of dementia: The Health in Men Study. PLoS ONE 6, e17902.
167. Beydoun MA, Beydoun HA, Wang Y (2008) Obesity and central obesity as risk factors for incident dementia and its subtypes: A systematic review and meta-analysis. Obes Rev 9, 204-218. (Pubitemid 351550691)
168. Profenno LA, Porsteinsson AP, Faraone SV (2010) Meta-analysis of Alzheimer's disease risk with obesity, diabetes, and related disorders. Biol Psychiatry 67, 505-512.
169. Atti AR, Palmer K, Volpato S, Winblad B, De Ronchi D, Fratiglioni L (2008) Late-life body mass index and dementia incidence: Nine-year follow-up data from the Kungsholmen Project. J Am Geriatr Soc 56, 111-116.
170. Luchsinger JA, Patel B, Tang MX, Schupf N, Mayeux R (2007) Measures of adiposity and dementia risk in elderly persons. Arch Neurol 64, 392-398. (Pubitemid 46425695)
171. Fitzpatrick AL, Kuller LH, Lopez OL, Diehr P, O'Meara ES, Longstreth WT Jr, Luchsinger JA (2009) Obesity: Risk of dementia in the Cardiovascular Health Cognition Study. Arch Neurol 66, 336-342.
172. Buchman AS, Wilson RS, Bienias JL, Shah RC, Evans DA, Bennett DA (2005) Change in body mass index and risk of incident Alzheimer disease. Neurology 65, 892-897. (Pubitemid 41362136)
173. Knopman DS, Edland SD, Cha RH, Petersen RC, Rocca WA (2007) Incident dementia in women is preceded by weight loss by at least a decade. Neurology 69, 739-746. (Pubitemid 47300930)
174. Panza F, D'Introno A, Colacicco AM, Capurso C, Pichichero G, Capurso SA, Capurso A, Solfrizzi V (2006) Lipid metabolism in cognitive decline and dementia. Brain Res Rev 51, 275-292. (Pubitemid 44183829)
175. Morley JE, Banks WA (2010) Lipids and cognition. J Alzheimers Dis 20, 737-747.
176. Frisardi V, Panza F, Solfrizzi V, Seripa D, Pilotto A (2010) Plasma lipid disturbances and cognitive decline. J Am Geri-atr Soc 58, 2429-2430.
177. Atzmon G, Gabriely I, Greiner W, Davidson D, Schechter C, Barzilai N (2002) Plasma HDL levels highly correlate with cognitive function in exceptional longevity. J Gerontol A Biol Sci Med Sci 57, M712-M715. (Pubitemid 35340550)
178. van Exel E, de Craen AJ, Gussekloo J, Houx P, Bootsma-van der Wiel A, MacFarlane PW, Blauw GJ, Westendorp RG (2002) Association between high-density lipoprotein and cognitive impairment in the oldest old. Ann Neurol 51, 716-721. (Pubitemid 34568850)
179. van Vliet P, van de Water W, de Craen AJM, Westendorp RGJ (2009) The influence of age on the association between cholesterol and cognitive function. Exp Gerontol 44, 112-122.
180. Henderson VW, Guthrie JR, Dennerstein L (2003) Serum lipids and memory in a population based cohort of middle age women. J Neurol Neurosurg Psychiatry 74, 1530-1535.
181. Reitz C, Luchsinger J, Tang MX, Manly J, Mayeux R (2005) Impactof plasma lipids and time onmemory performance in healthy elderly without dementia. Neurology64, 1378-1383. (Pubitemid 40570505)
182. Reitz C, Tang MX, Manly J, Schupf N, Mayeux R, Luchsinger JA (2008) Plasma lipid levels in the elderly are not associated with the risk of mild cognitive impairment. Dement Geriatr Cogn Disord 25, 232-237. (Pubitemid 351363887)
183. Yaffe K, Barrett-Connor E, Lin F, Grady D (2002) Serum lipoprotein levels, statin use, and cognitive function in older women. Arch Neurol 59, 378-384. (Pubitemid 34208144)
184. Singh-Manoux A, Gimeno D, Kivimaki M, Brunner E, Marmot MG (2008) Low HDL cholesterol is a risk factor for deficit and decline in memory in midlife: The Whitehall II study. Arterioscler Thromb Vasc Biol 28, 1556-1562.
185. Reynolds CA, Gatz M, Prince JA, Berg S, Pedersen NL (2010) Serum lipid levels and cognitive change in late life. J Am Geriatr Soc 58, 501-509.
186. Yasuno F, Tanimukai S, Sasaki M, Hidaka S, Ikejima C, Yamashita F, Kodama C, Mizukami K, Michikawa M, Asada T (2011) Association between cognitive function and plasma lipids of the elderly after controlling for apolipoprotein e genotype. Am J Geriatr Psychiatry, doi: 10.1097/JGP.0b013e318211819b.
187. Perlmuter LC, Nathan DM, Goldfinger SH, Russo PA, Yates J, Larkin M (1988) Triglyceride levels affect cognitive function in noninsulin-dependent diabetics. J Diabet Complications 2, 210-213.
188. Sims R, Madhere S, Callender C, Campbell A Jr (2008) Patternsofrelationships between cardiovascular disease risk factors and neurocognitive function in African Americans. Ethn Dis 18, 471-476.
189. de Frias CM, Bunce D, Wahlin A, Adolfsson R, Sleegers K, Cruts M, Van Broeckhoven C, Nilsson LG (2007) Cholesterol and triglycerides moderate the effect of apolipoprotein E on memory functioning in older adults. J Gerontol B Psychol Sci Soc Sci 62, 112-118.
190. Reitz C, Tang MX, Luchsinger J, Mayeux R (2004) Relation of plasma lipidstoAlzheimer disease andvascular dementia. Arch Neurol 61, 705-714. (Pubitemid 38637688)
191. Lesser G, Kandiah K, Libow LS, Likourezos A, Breuer B, Marin D, Mohs R, Haroutunian V, Neufeld R (2001) Elevated serum total and LDL cholesterol in very old patients with Alzheimer's disease. Dement Geriatr Cogn Disord 12, 138-145. (Pubitemid 32149720)
192. Lehtonen A, Luutonen S (1986) High-density lipoprotein cholesterol levels of very old people in the diagnosis of dementia. Age Ageing 15, 267-270. (Pubitemid 16013579)
193. Moroney JT, Tang MX, Berglund L, Small S, Merchant C, Bell K, Stern Y, Mayeux R (1999) Low-density lipoprotein cholesterol and the risk of dementia with stroke. JAMA 282, 254-260. (Pubitemid 29343168)
194. Kim JM, Stewart R, Shin IS, Yoon JS (2002) Low cholesterol, cognitive function and Alzheimer's disease in a community population with cognitive impairment. J Nutr Health Aging 6, 320-323. (Pubitemid 36118980)
195. Caramelli P, Nitrini R, Maranhão R, Lourenço AC, Damasceno MC, Vinagre C, Caramelli B (1999) Increased apolipoprotein B serum concentration in Alzheimer's disease. Acta Neurol Scand 100, 61-63. (Pubitemid 29292552)
196. Bonarek M, Barberger-Gateau P, Letenneur L, Deschamps V, Iron A, Dubroca B, Dartigues JF (2000) Relationships between cholesterol, apolipoprotein E polymorphism and dementia: A cross-sectional analysis from the PAQUID study. Neuroepidemiology 19, 141-148. (Pubitemid 30146444)
197. Launer LJ, White LR, Petrovitch H, Ross GW, Curb JD (2001) Cholesterol and neuropathologic markers of AD: A population-based autopsy study. Neurology 57, 1447-1452. (Pubitemid 32995727)
198. Merched A, Xia Y, Visvikis S, Serot JM, Siest G (2000) Decreased high-density lipoprotein cholesterol and serum apolipoprotein AI concentrations are highly correlated with the severity of Alzheimer's disease. Neurobiol Aging 21, 27-30. (Pubitemid 30224782)
199. Wolf H, Hensel A, Arendt T, Kivipelto M, Winblad B, Gertz HJ (2004) Serum lipids and hippocampal volume: The link to Alzheimer's disease? Ann Neurol 56, 745-748. (Pubitemid 39540761)
200. Reitz C, Tang MX, Schupf N, Manly JJ, Mayeux R, Luchsinger JA (2010) Association of higher levels of high-density lipoprotein cholesterol in elderly individuals and lower risk of late-onset Alzheimer disease. Arch Neurol 67, 1491-1497.
201. Helzner EP, Luchsinger JA, Scarmeas N, Cosentino S, Brickman AM, Glymour MM, Stern Y (2009) Contribution of vascular risk factors to the progression in Alzheimer disease. Arch Neurol 66, 343-348.
202. Tan ZS, Seshadri S, Beiser A, Wilson PW, Kiel DP, Tocco M, D'Agostino RB, Wolf PA (2003) Plasma total cholesterol levelasarisk factor for Alzheimer disease: The Framingham Study. Arch Intern Med 163, 1053-1057. (Pubitemid 36548931)
203. Zuliani G, Cavalieri M, Galvani M, Volpato S, Cherubini A, Bandinelli S, Corsi AM, Lauretani F, Guralnik JM, Fellin R, Ferrucci L (2010) Relationship between low levels of high-density lipoprotein cholesterol and dementia in the elderly. The InChianti study. J Gerontol A Biol Sci Med Sci 65, 559-564.
204. Muckle TJ, Roy JR (1985) High-density lipoprotein cholesterol in differential diagnosis of senile dementia. Lancet 1, 1191-1193. (Pubitemid 15083674)
205. Zuliani G, Ble' A, Zanca R, Munari MR, Zurlo A, Vavalle C, Atti AR, Fellin R (2001) Lipoprotein profile in older patients with vascular dementia and Alzheimer's disease. BMC Geriat 1, 5.
206. Kálmán J, Kudchodkar BJ, Murray K, McConathy WJ, Juhász A, Janka Z, Lacko AG (1999) Evaluation of serum-lipid-related cardiovascular risk factors in Alzheimer's disease. Dement Geriatr Cogn Dis 10, 488-493. (Pubitemid 29512017)
207. Mathew NT, Meyer JS, Achari AN, Dodson RF (1976) Hyperlipidemic neuropathy and dementia. Eur Neurol 14, 370-382.
208. Heilman KM, Fisher WR (1974) Hyperlipidemic dementia. Arch Neurol 31, 67-68.
209. Kalmijn S, Foley D, White L, Burchfiel CM, Curb JD, Petrovitch H, Ross GW, Havlik RJ, Launer LJ (2000) Metabolic cardiovascular syndrome and risk of dementia in Japanese-American elderly men. The Honolulu-Asia aging study. Arterioscler Thromb Vasc Biol 20, 2255-2260.
210. Ferreira IL, Resende R, Ferreiro E, Rego AC, Pereira CF (2010) Multiple defects in energy metabolism in Alzheimer's disease. Curr Drug Targets 11, 1193-1206.
211. Dik MG, Jonker C, Comijs HC, Deeg DJ, Kok A, Yaffe K, Penninx BW (2007) Contribution of metabolic syndrome components to cognition in older individuals. Diabetes Care 30, 2655-2660. (Pubitemid 47547816)
212. van den Berg E, Dekker JM, Nijpels G, Kessels RP, Kappelle LJ, de Haan EH, Heine RJ, Stehouwer CD, Bies-sels GJ (2008) Cognitive functioning in elderly persons with type 2 diabetes and metabolic syndrome: The Hoorn study. Dement Geriatr Cogn Disord 26, 261-269.
213. Laudisio A, Marzetti E, Pagano F, Cocchi A, Franceschi C, Bernabei R, Zuccalà G (2008) Association of metabolic syndrome with cognitive function: The role of sex and age. Clin Nutr 27, 747-754.
214. Liu CY, Zhou HD, Xu ZQ, Zhang WW, Li XY, Zhao J (2009) Metabolic syndrome and cognitive impairment amongst elderly people in Chinese population: A cross-sectional study. Eur J Neurol 16, 1022-1027.
215. Muller M, van Raamt F, Visseren FL, Kalmijn S, Geerlings MI, Mali WP, van der Graaf Y, SMART Study (2010) Metabolic syndrome and cognition in patients with manifest atherosclerotic disease: The SMART study. Neu-roepidemiology 34, 83-89.
216. Cavalieri M, Ropele S, Petrovic K, Pluta-Fuerst A, Homay-oon N, Enzinger C, Grazer A, Katschnig P, Schwingenschuh P, Berghold A, Schmidt R (2010) Metabolic syndrome, brain magnetic resonance imaging, and cognition. Diabetes Care 33, 2489-2495.
217. Lee KS, Jang Y, Chung YK, Chung JH, Oh BH, Hong CH (2009) Relationship between the diagnostic components of metabolic syndrome (MS) and cognition by ApoE genotype in the elderly. Arch Gerontol Geriatr 50, 69-72.
218. Tournoy J, Lee DM, Pendleton N, O'Neill TW, O'Connor DB, Bartfai G, Casanueva FF, Finn JD, Forti G, Giwercman A, Han TS, Huhtaniemi IT, Kula K, Lean ME, Moseley CM, Punab M, Silman AJ, Vanderschueren D, Wu FC, Boonen S, EMAS study group (2010) Association of cognitive performance with the metabolic syndrome and with glycaemia in middle-aged and older European men: The European Male Ageing Study. Diabetes Metab Res Rev 26, 668-676.
219. Yaffe K, Kanaya A, Lindquist K, Simonsick EM, Harris T, Shorr RI, Tylavsky FA, Newman AB (2004) The metabolic syndrome, inflammation, and risk of cognitive decline. JAMA 292, 2237-2242. (Pubitemid 39473161)
220. Yaffe K, Haan M, Blackwell T, Cherkasova E, Whitmer RA, West N (2007) Metabolic syndrome and cognitive decline in elderly Latinos: Findings from the Sacramento Area Latino Study of Aging study. J Am Geriatr Soc 55, 758-762. (Pubitemid 46668964)
221. Komulainen P, Lakka TA, Kivipelto M, Hassinen M, Helkala EL, Haapala I, Nissinen A, Rauramaa R (2007) Metabolic syndrome and cognitive function: A population-based follow-up study in elderly women. Dement Geriatr Cogn Disord 23, 29-34. (Pubitemid 46005788)
222. Ho RC, Niti M, Yap KB, Kua EH, Ng TP (2008) Metabolic syndrome and cognitive decline in chinese older adults: Results from the Singapore longitudinal ageing studies. Am J Geriatr Psychiatry 16, 519-522.
223. Lee KS, Eom JS, Cheong HK, Oh BH, Hong CH (2010) Effects of head circumference and metabolic syndrome on cognitive decline. Gerontology 56, 32-38.
224. Akbaraly TN, Kivimaki M, Shipley MJ, Tabak AG, Jokela M, Virtanen M, Marmot MG, Ferrie JE, Singh-Manoux A (2010) Metabolic syndrome over 10 years and cognitive functioning in late midlife: The Whitehall II study. Diabetes Care 33, 84-89.
225. Raffaitin C, Féart C, Le Goff M, Amieva H, Helmer C, Akbaraly TN, Tzourio C, Gin H, Barberger-Gateau P (2011) Metabolic syndrome and cognitive decline in French elders: The Three-City Study. Neurology 76, 518-525.
226. van den Berg E, Biessels GJ, de Craen AJ, Gussekloo J, Westendorp RG (2007) The metabolic syndrome is associated with decelerated cognitive decline in the oldest old. Neurology 69, 979-985. (Pubitemid 47366051)
227. Hassenstab JJ, Sweat V, Bruehl H, Convit A (2010) Metabolic syndrome is associated with learning and recall impairment in middle age. Dement Geriatr Cogn Disord 29, 356-362.
228. Hudetz JA, Patterson KM, Iqbal Z, Gandhi SD, Pagel PS (2011) Metabolic syndrome exacerbates short-term postoperative cognitive dysfunction in patients undergoing cardiac surgery: Resultsofapilot study. J Cardiothorac Vasc Anesth 25, 282-287.
229. Hudetz JA, Patterson KM, Amole O, Riley AV, Pagel PS (2011) Postoperative cognitive dysfunction after noncardiac surgery: Effects of metabolic syndrome. J Anesth 25, 337-344.
230. Roberts RO, Geda YE, Knopman DS, Cha RH, Boeve BF, Ivnik RJ, Pankratz VS, Tangalos EG, Petersen RC (2010) Metabolic syndrome, inflammation, and nonamnestic mild cognitive impairment in older persons: A Population-based study. Alzheimer Dis Assoc Disord 24, 11-18.
231. Yaffe K, Weston AL, Blackwell T, Krueger KA (2009) The metabolic syndrome and development of cognitive impairment among older women. Arch Neurol 66, 324-328.
232. Solfrizzi V, Scafato E, Capurso C, D'Introno A, Colacicco AM, Frisardi V, Vendemiale G, Baldereschi M, Crepaldi G, Di Carlo A, Galluzzo L, Gandin C, Inzitari D, Maggi S, Capurso A, Panza F, Italian Longitudinal Study on Aging Working Group (2011) Metabolic syndrome, mild cognitive impairment, and progression to dementia. The Italian Longitudinal Study on Aging. Neurobiol Aging 32 1932-1941.
233. Vanhanen M, Koivisto K, Moilanen L, Helkala EL, Hanninen T, Soininen H, Kervinen K, Kesaniemi YA, Laakso M, Kuusisto J (2006) Association of metabolic syndrome with Alzheimer disease: A population-based study. Neurology 67, 843-847. (Pubitemid 44394200)
234. Roriz-Cruz M, Rosset I, Wada T, Sakagami T, Ishine M, De Sá Roriz-Filho J, Cruz TR, Hosseinkhani M, Rodrigues RP, Sudoh S, Arai H, Wakatsuki Y, Souza AC, Nakagawa M, Kita T, Matsubayashi K (2007) Cognitive impairment and frontal-subcortical geriatric syndrome are associated with metabolic syndrome in a stroke-free population. Neurobiol Aging 28, 1723-1736. (Pubitemid 47384947)
235. Muller M, Tang MX, Schupf N, Manly JJ, Mayeux R, Luchsinger JA (2007) Metabolic syndrome and dementia risk in a multiethnic elderly cohort. Dement Geriatr Cogn Disord 24, 185-192. (Pubitemid 47312668)
236. Raffaitin C, Gin H, Empana JP, Helmer C, Berr C, Tzourio C, Portet F, Dartigues JF, Alpérovitch A, Barberger-Gateau P (2009) Metabolic syndrome and risk for incident Alzheimer's disease or vascular dementia: The Three-City Study. Diabetes Care 32, 169-174.
237. Solfrizzi V, Scafato E, Capurso C, D'Introno A, Colacicco AM, Frisardi V, Vendemiale G, Baldereschi M, Crepaldi G, Di Carlo A, Galluzzo L, Gandin C, Inzitari D, Maggi S, Capurso A, Panza F, Italian Longitudinal Study on Aging Working Group (2010). Metabolic syndrome and the risk of vascular dementia. TheItalian LongitudinalStudyonAging. J Neurol Neurosurg Psychiatry 81, 433-440.
238. Forti P, Pisacane N, Rietti E, Lucicesare A, Olivelli V, Mariani E, Mecocci P, Ravaglia G (2010) Metabolic syndrome and risk of dementia in older adults. J Am Geriatr Soc 58, 487-492.
239. Pugh KG, Lipsitz LA (2002) The microvascular frontal-subcortical syndrome of aging. Neurobiol 23, 421-431. (Pubitemid 34312026)
240. Schuur M, Henneman P, van Swieten JC, Zillikens MC, de Koning I, Janssens AC, Witteman JC, Aulchenko YS, Frants RR, Oostra BA, van Dijk KW, van Duijn CM (2010) Insulinresistance and metabolic syndrome are related to executive function in women in a large family-based study. Eur J Epidemiol 25, 561-568.
241. Segura B, Jurado MA, Freixenet N, Albuin C, Muniesa J, Junqué C (2009) Mental slowness and executive dysfunctions in patients with metabolic syndrome. Neurosci Lett 462, 49-53.
242. Bokura H, Nagai A, Oguro H, Kobayashi S, Yamaguchi S (2010) The association of metabolic syndrome with execu tive dysfunction independent of subclinical ischemic brain lesions in Japanese adults. Dement Geriatr Cogn Disord 30, 479-485.
243. Razay G, Vreugdenhil A, Wilcock G (2007) The metabolic syndrome and Alzheimer disease. Arch Neurol 64, 93-96. (Pubitemid 46072429)
244. García-Lara JM, Aguilar-Navarro S, Gutiérrez-Robledo LM, Avila-Funes JA (2010) The metabolic syndrome, diabetes, and Alzheimer's disease. Rev Invest Clin 62, 343-349.
245. Vilalta-Franch J, Lopez-Pousa S, Garre-Olmo J, Turón-Estrada A, Pericot-Nierga I (2008) Metabolic syndrome in Alzheimer's disease: Clinical and developmental influences [Spanish]. Rev Neurol 46, 13-17. (Pubitemid 351162427)
246. Frisard MI, Rood JC, Fang X, Su J, Welsh DA, Jazwinski SM, Ravussin E, Louisiana Healthy Aging Study (2009) Metabolic syndrome and risk factors for cardiovascular disease: Are nonagenarians protected? Age 31, 67-75.
247. Kandiah N, Feldman HH (2009) Therapeutic potential of statins in Alzheimer's disease. J Neurol Sci 283, 230-234.
248. Annweiler C, Allali G, Allain P, Bridenbaugh S, Schott AM, Kressig RW, Beauchet O (2009) Vitamin D and cognitive performance in adults: A systematic review. Eur J Neurol 16, 1083-1108.
249. Annweiler C, Schott AM, Allali G, Bridenbaugh SA, Kressig RW, Allain P, Herrmann FR, Beauchet O (2010) Association of vitamin D deficiency with cognitive impairment in older women: Cross-sectional study. Neurology 74, 27-32.
250. Dickens AP, Lang IA, Langa KM, Kos K, Llewellyn DJ (2011) Vitamin D, cognitive dysfunction and dementia in older adults. CNS Drugs 25, 629-639.
251. Buell JS, Dawson-Hughes B, Scott TM, Weiner DE, Dallal GE, Qui WQ, Bergethon P, Rosenberg IH, Folstein MF, Patz S, Bhadelia RA, Tucker KL (2010) 25-Hydroxyvitamin D, dementia, and cerebrovascular pathology in elders receiving home services. Neurology 74, 18-26.
252. Parker J, Hashmi O, Dutton D, Mavrodaris A, Stranges S, Kandala NB, Clarke A, Franco OH (2010) Levels of vitamin D and cardiometabolic disorders: Systematic review and meta-analysis. Maturitas 65, 225-236.
253. Chacko SA, Song Y, Manson JE, Van Horn L, Eaton C, Martin LW, McTiernan A, Curb JD, Wylie-Rosett J, Phillips LS, Plodkowski RA, Liu S (2011) Serum 25-hydroxyvitamin D concentrations in relation to cardiometabolic risk factors and metabolic syndrome in postmenopausal women. Am J Clin Nutr 94, 209-217.
254. Burgaz A, Orsini N, Larsson SC, Wolk A (2011) Blood 25-hydroxyvitamin D concentration and hypertension: A meta-analysis. J Hypertens 29, 636-645.
255. Gupta AK, Brashear MM, Johnson WD (2011) Prediabetes and prehypertension in healthy adults are associated with low vitamin D levels. Diabetes Care 34, 658-660.
256. Mitri J, Muraru MD, Pittas AG (2011) Vitamin D and type 2 diabetes: A systematic review. Eur J Clin Nutr 65, 1005-1015.
257. Annweiler C, Rolland Y, Schott AM, Blain H, Vellas B, Herrmann FR, Beauchet O (2012) Higher vitamin D dietary intake is associated with lower risk of Alzheimer's disease: A 7-year follow-up. J Gerontol A Biol Sci Med Sci, doi: 10.1093/gerona/gls107.
258. Koch L, Wunderlich FT, Seibler J, Konner AC, Hampel B, Irlenbusch S, Brabant G, Kahn CR, Schwenk F, Bruning JC (2008) Central insulin action regulates peripheral glucose and fat metabolism in mice. J Clin Invest 118, 2132-2147. (Pubitemid 351872332)
259. Milanski M, Degasperi G, Coope A, Morari J, Denis R, Cintra DE, Tsukumo DM, Anhe G, Amaral ME, Takahashi HK, Curi R, Oliveira HC, Carvalheira JB, Bordin S, Saad MJ, Velloso LA (2009) Saturated fatty acids produce an inflammatory response predominantly through the activation of TLR4 signaling in hypothalamus: Implications for the pathogenesis of obesity. J Neurosci 29, 359-370.
260. Bhat NR (2010) Linking cardiometabolic disorders to sporadic Alzheimer's disease: A perspective on potential mechanisms and mediators. J Neurochem 115, 551-562.